title: [NSAID GASTROPATHY IN PATIENTS WITH COMORBID DISEASES].
abstract: The widespread use in clinical practice of non-steroidal anti-inflammatory drugs (NSAIDs), largely due to the general trend towards an aging population and, as a consequence, increase the number of individuals with comorbid conditions and diseases, including the most common are diseases of the cardiovascular system, diseases of the joints and spine, requiring of therapy with, combining the anti-inflammatory and analgesic properties. However, NSAIDs not only have favorable effects, but have quite a wide range of adverse effects, an important place among which is NSAID-induced gastropathy. The article deals with the rational choice of NSAIDs in patients depending on the degree of cardiovascular risk and gastrointenstinalnogo, as well as the possibility of preventing NSAID-associated gastropathy. Particular attention is paid to the choice of individual NSAIDs with regard to their pharmacological properties.
authors.forename: T E
authors.initials: TE
authors.lastname: Morozova
authors.forename: S M
authors.initials: SM
authors.lastname: Rykova
authors.forename: M A
authors.initials: MA
authors.lastname: Chukina
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy; D005767:Gastrointestinal Diseases / Q000139:chemically induced*; D006801:Humans; D007592:Joint Diseases / Q000188:drug therapy; D013122:Spinal Diseases / Q000188:drug therapy
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal